7NRY | pdb_00007nry

Re-refinement of MAPKAP kinase-2/inhibitor complex 3fyj


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.80 Å
  • R-Value Free: 
    0.275 (Depositor), 0.293 (DCC) 
  • R-Value Work: 
    0.234 (Depositor), 0.242 (DCC) 
  • R-Value Observed: 
    0.235 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7NRY

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Re-refinement Note

This entry reflects an alternative modeling of the original data in: 3fhr

Literature

Adaptive Cartesian and torsional restraints for interactive model rebuilding.

Croll, T.I.Read, R.J.

(2021) Acta Crystallogr D Struct Biol 77: 438-446

  • DOI: https://doi.org/10.1107/S2059798321001145
  • Primary Citation Related Structures: 
    7NRB, 7NRY

  • PubMed Abstract: 

    When building atomic models into weak and/or low-resolution density, a common strategy is to restrain their conformation to that of a higher resolution model of the same or similar sequence. When doing so, it is important to avoid over-restraining to the reference model in the face of disagreement with the experimental data. The most common strategy for this is the use of `top-out' potentials. These act like simple harmonic restraints within a defined range, but gradually weaken when the deviation between the model and reference grows beyond that range. In each current implementation the rate at which the potential flattens at large deviations follows a fixed form, although the form chosen varies among implementations. A restraint potential with a tuneable rate of flattening would provide greater flexibility to encode the confidence in any given restraint. Here, two new such potentials are described: a Cartesian distance restraint derived from a recent generalization of common loss functions and a periodic torsion restraint based on a renormalization of the von Mises distribution. Further, their implementation as user-adjustable/switchable restraints in ISOLDE is described and their use in some real-world examples is demonstrated.


  • Organizational Affiliation
    • Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, United Kingdom.

Macromolecule Content 

  • Total Structure Weight: 38.41 kDa 
  • Atom Count: 2,339 
  • Modeled Residue Count: 283 
  • Deposited Residue Count: 327 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
MAP kinase-activated protein kinase 2A [auth X]327Homo sapiensMutation(s): 0 
Gene Names: MAPKAPK2
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for P49137 (Homo sapiens)
Explore P49137 
Go to UniProtKB:  P49137
PHAROS:  P49137
GTEx:  ENSG00000162889 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP49137
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
B97

Query on B97



Download:Ideal Coordinates CCD File
B [auth X](10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one
C21 H18 N4 O S
CMWRPDHVGMHLSZ-GFCCVEGCSA-N
MLA

Query on MLA



Download:Ideal Coordinates CCD File
D [auth X]MALONIC ACID
C3 H4 O4
OFOBLEOULBTSOW-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
C [auth X]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.80 Å
  • R-Value Free:  0.275 (Depositor), 0.293 (DCC) 
  • R-Value Work:  0.234 (Depositor), 0.242 (DCC) 
  • R-Value Observed: 0.235 (Depositor) 
Space Group: F 41 3 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 255.551α = 90
b = 255.551β = 90
c = 255.551γ = 90
Software Package:
Software NamePurpose
ISOLDErefinement
PHENIXrefinement
DENZOdata reduction
SCALEPACKdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Wellcome TrustUnited Kingdom209407/Z/17/Z

Revision History  (Full details and data files)

  • Version 1.0: 2022-02-09
    Type: Initial release
  • Version 1.1: 2024-01-31
    Changes: Data collection, Refinement description